ArticleScientific reports2026

Blood parameters and whole-blood transcriptomics associated with immune-related adverse events in metastatic renal cell carcinoma during nivolumab plus ipilimumab.

Satoka Kinase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.